A Vertex Pharmaceuticals company driving the next generation of endocrinology care. Social guidelines: https://xitter.cf/t.co/ncgkUbAaLd
San Diego, CA
Joined September 2016
- Tweets794
- Following520
- Followers1.1K
- Likes1.5K
Crinetics Pharmaceuticals retweeted
🦓Today is #NETCancerDay! Today we unite in one global voice to speak about neuroendocrine cancer and call for more NET awareness among HCPs, which will help them suspect it and diagnose it early.
📢Share our messages in 11 languages: incalliance.org/ncd-2023/ #LetsTalkAboutNETs
Crinetics Pharmaceuticals retweeted
Join us TOMORROW, August 8th, at 12pm ET for a KOL Webinar with @Crinetics, featuring Beverly MK Biller, M.D. and Karen JP Liebert, R.N., BSN, on the current treatment landscape and unmet medical need in #acromegaly.
Register here: fal.cn/3AwBZ $CRNX
Crinetics Pharmaceuticals retweeted
There is still time to take part in some of our CAH Awareness Month initiatives in 2023! Please visit the links below: #cah #cahawarenessmonth #cares #advocacy #raredisease #caresfoundation #june2023
Crinetics Pharmaceuticals retweeted
From #ENDO2023
@TheEndoSociety president Ursula Kaiser and 2023 Baxter Prize winner @rsstruthers
Crinetics Pharmaceuticals retweeted
Healio spoke with John D. Baxter Prize for Entrepreneurship honoree R. Scott Struthers, PhD, who predicts, “Drug discovery in endocrinology is starting to take off. We’ll see a bunch of new therapeutic agents.” #ENDO2023 @TheEndoSociety bit.ly/3X6IwEl
Crinetics Pharmaceuticals retweeted
#ENDO2023 Preview:
Don't miss the John D. Baxter Prize for Entrepreneurship Lecture on Thursday June 15, 2023, at 10 AM, as @Crinetics CEO @rsstruthers shares his Adventures Discovering Nonpeptide Oral Drugs Acting at Peptide Hormone Receptors:
bit.ly/3WY2GAq
Crinetics Pharmaceuticals retweeted
A pleasure to participate in the @Crinetics Scientific Advisory Board meeting, with many engaging discussions. @EndocrineMgh fellowship alumni were well represented!
Crinetics Pharmaceuticals retweeted
Please join us on 11/10 @ 7 pm for a very special #SmilowShares webinar for patients with #NETs and their caregivers/family members.
👇🏼Registration link below. 🦓
yale.zoom.us/webinar/registe…
Crinetics Pharmaceuticals retweeted
Join us for the inaugural CHI Family Meet-Up in Santa Monica on Nov. 5. Julie Raskin will be presenting on the rare disease patient registry movement and our HI Global Registry. This event was made possible with a grant from @globalgenes. Register today: bit.ly/3CTrOQF
Crinetics Pharmaceuticals retweeted
Finally wrapped up a very productive day of @NANETS1 at 10:30 PM. Was honored to lead Paltusotine steering committee. Discussing our Paltusotine Ph2 Trials in Progress poster with @LowellAnthonyMD . So happy to bring Oral SSA to NETs patients!! 🦓
Crinetics Pharmaceuticals retweeted
Somatostatin Analogs were/are a game changer for carcinoid syndrome management. Years later, we have an opportunity to explore a non injectable alternative!! Excited to present the Phase 2 study poster at #NANETS22 Lets catch up ☕️and marvel over all the cool drug dev in #NETs 🦓
Join us for a poster presentation by study co-author Dr. @AmanChauhanMD at @NANETS. Dr. Chauhan will be reviewing our open label, randomized, Phase 2 study for the treatment of #CarcinoidSyndrome. Schedule: bit.ly/3TDjLgm #NANETS2022 #crinetics
Crinetics Pharmaceuticals retweeted
Our first episode of @netsgetreal is live on all streaming platforms and our YouTube Channel! This episode features Mary Maluccio, MD, MPH, FACS talking about Clinical Trials!
#NeuroendocrineCancer #NeuroendocrineTumor #NETs #ZebraStrong #NETCancerAwareness #NCAN #CancerSupport
Crinetics Pharmaceuticals retweeted
A special thank you to our conference sponsors for helping make today's conference possible!
@adacap_news
@LantheusNews
@TesseraTx
RayzeBio
@IpsenUS
@Crinetics
Watch live now!
We are live with 10 NET experts in OUR HOUR! Tune in here: lacnets.org/2022
#lacnets2022 #neuroendocrinecancer #neuroendocrinetumor #netcancer
Crinetics Pharmaceuticals retweeted
And that’s a wrap for #ENDO2022! 47 million impressions on this hashtag 🤯
Pretty sure that smashes the previous record, right @TheEndoSociety? Thanks to everyone on Twitter and see you next year in Chicago for #ENDO2023!
Thank you so much to our AMSC (bit.ly/3NUZuju), our presenters, our sponsors, our exhibitors, and our attendees for making the ENDO hybrid meeting a great success! Please continue the #endocrinology and hormone research conversations by using #ENDO2022
Crinetics Pharmaceuticals retweeted
Share our emergency cards, in English, Russian & Ukrainian, to help quickly identify refugee patients & ensure patients get essential treatment. ow.ly/mJOj50ICSxk @AddisonsUK @AmendInfo @ParathyroidUK @TurnerSyndSoc @WAPO_org @BNvacp @ipwso @FranceHypopara @MEN_Alliance
Crinetics Pharmaceuticals retweeted
On #WorldHealthDay2022 let’s stress again that more awareness is needed to improve healthcare in #neuroendocrinecancer. Only 27% of NET patients have been diagnosed at once, up to 50% misdiagnosed for years. Check SCAN in 10 languages: incalliance.org/scan/ #LetsTalkAboutNETs
Crinetics Pharmaceuticals retweeted
#WorldHealthDay is today! It is a reminder of the importance of raising awareness about congenital hyperinsulinism + hypoglycemia to improve the lives of people with hyperinsulinism around the world.
CHI posters are available in 23 languages: bit.ly/3h3fDUU
Crinetics Pharmaceuticals retweeted
CHI has a full calendar of in-person + virtual events! Save the dates, so you can be a part of them all. More details about registering and participating in our events will be shared in the upcoming months. Stay updated: bit.ly/3i3jeDU
#hypoglycemia #hyperinsulinism
Crinetics Pharmaceuticals retweeted
This is an ESE 2022 Young Investigator Award! Well done Ross! So delighted to see once more the success of our pituitary fellows and that our collaborative studies are flourishing! @BHPComms @ESEndocrinology @PituitarySoc @ENEAssoc @ENEA_Young
Congratulations to Dr @RossHamblin for being awarded for his abstract 'Radiotherapy for adults with pituitary adenoma or craniopharyngioma is associated with increased risk of second brain tumour'. He will present this at the @ESEndocrinology in Milan in May. @Karavitaki_Niki
